Facebook Linkedin Twitter
Inside Precision Medicine Oncolytic Virus Treatment May Boost Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer

Breast cancer. TNBC
News & Features

Oncolytic Virus Treatment May Boost Chemotherapy Response in Triple-Negative Breast Cancer

Chris Anderson -
0
Close-Up Of Cropped Hands Inserting Syringe Into Vial of prototype gonorrhea vaccine
News & Features

Cancer Vaccines Get Structural Remake

Christina Jackson -
0
Woman examining her breasts for cancer
News & Features

New Target for Triple Negative Breast Cancer

Malorye Branca -
0
Low grade ductal carcinoma with positive estrogen receptor
News & Features

Residual Breast Cancer Immunologic Pathways Identified

Chris Anderson -
0
Outline X-ray type illustration of a woman with breast cancer.
News & Features

Triple-Negative Breast Cancer’s Metastatic Drivers Revealed

Julianna LeMieux, PhD -
0
Inmunologically active proteins on a T-cell: T-cell receptor, CD-4, CD-28, PD-1 and CTLA-4 and a calcium channel. Cancer Immunotherapy
News & Features

Combo-Therapy Trial of Aggressive Breast Cancer Provides Results by Race

Chris Anderson -
0
Chemotherapy Efficacy May Be Aided by Epigenetic Treatments
News & Features

Chemotherapy Efficacy May Be Aided by Epigenetic Treatments

Chris Anderson -
0
3D image of breast cancer metastasizing representing HER2 breast cancer.
News & Features

Cardamonin Shows Promise in Triple Negative Breast Cancer Lab Studies

Malorye Branca -
0
3D image of breast cancer metastasizing representing HER2 breast cancer.
News & Features

GIT1 Protects Against Breast Cancer Growth

Malorye Branca -
0
Triple negative breast cancer cell undergoing retraction and apoptosis
News & Features

CECR2 May Have Key Role in Triple-Negative Breast Cancer

Malorye Branca -
0
1234Page 2 of 4

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine